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Collagen hydrogels are among the most well-studied platforms for drug delivery and in situ tissue engineering,
thanks to their low cost, low immunogenicity, versatility, biocompatibility, and similarity to the natural extra-
cellular matrix (ECM). Despite collagen being largely responsible for the tensile properties of native connective
tissues, collagen hydrogels have relatively low mechanical properties in the absence of covalent cross-linking. This
is particularly problematic when attempting to regenerate stiffer and stronger native tissues such as bone.
Furthermore, in contrast to hydrogels based on ECM proteins such as fibronectin, collagen hydrogels do not have
any growth factor (GF)-specific binding sites and often cannot sequester physiological (small) amounts of the
protein. GF binding and in situ presentation are properties that can aid significantly in the tissue regeneration
process by dictating cell fate without causing adverse effects such as malignant tumorigenic tissue growth. To
alleviate these issues, researchers have developed several strategies to increase the mechanical properties of
collagen hydrogels using physical or chemical modifications. This can expand the applicability of collagen
hydrogels to tissues subject to a continuous load. GF delivery has also been explored, mathematically and
experimentally, through the development of direct loading, chemical cross-linking, electrostatic interaction, and
other carrier systems. This comprehensive article explores the ways in which these parameters, mechanical
properties and GF delivery, have been optimized in collagen hydrogel systems and examines their in vitro or in vivo
biological effect. This article can, therefore, be a useful tool to streamline future studies in the field, by pointing
researchers into the appropriate direction according to their collagen hydrogel design requirements.1. Introduction
Collagen is the most abundant protein in the animal kingdom and is a
key component of the extracellular matrix (ECM). There are at least 28
members that belong to the collagen superfamily; however, the defining
characteristics of collagen can be quite loose. Over 90% of collagen in the
human body is either type I, II, or III [1]. This article will focus on
collagen type I, the most widely used collagen in tissue engineering,
which is made up of three alpha chains (two α1 and one α2). Some exist
in the form of an α1 homotrimer albeit in small amounts [1]. Each
collagen chain is made up of approximately 1000 amino acids following a
Gly-X-Y repeating sequence. X and Y being usually proline and hy-
droxyproline, respectively [2] (Fig. 1).
Because of its ubiquity, collagen is also easily and cheaply isolated
from tissues such as skin, tendon, pericardium, and other and is widelyow.ac.uk (M. Salmeron-Sanchez)
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evier Ltd. This is an open accessused as a biomaterial, such as hydrogels (materials with a water content
>90%), for tissue regeneration. Commonly it is extracted not only from
bovine, porcine, or rat specimens but also from marine or recombinant
sources [3]. It can be isolated using acid or enzymes such as pepsin and
can be found in two forms: as atelocollagen (without telopeptides) or
telocollagen (with telopeptides) (Fig. 1). The free functional groups of
collagens (amines and carboxyl) can be used to modify their structure
and be used to create physical or chemical cross-links [4] (Fig. 1). The
ability of collagen to form intra- and interfibrillar cross-links can be
exploited to create hydrogels with a range of mechanical properties to
match the ones showcased by the surrounding tissue when implanted. A
general compilation of cross-linking strategies for hydrogels and other
biomaterials has been undertaken by other authors [5,6]. However, the
impact on the mechanical properties of collagen hydrogels has only been
reviewed considering mainly non-covalent cross-linking mechanisms [7,.
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Fig. 1. A Type 1 collagen structure shows the triple helix (made up of two α1 and one α2 chains) and the N- and C-terminal telo- and pro-peptides of a collagen type I
molecule. B Collagen type I is gelled using various methods discussed later to form a hydrogel system. Cross-linking is carried out by taking advantage of collagen's free
amine and carboxyl groups. Example of collagen–cell interaction through GFOGER-integrin ligation.
S.O. Sarrigiannidis et al. Materials Today Bio 10 (2021) 1000988], or specialized applications such as 3D printing [9,10].
Collagen is also a highly biocompatible material, which provides the
ideal environment for cell attachment and proliferation [11], making it a
great candidate for use in tissue regeneration. It is mostly broken down
through enzymatic pathways, in contrast to synthetic polymers, which
degrade hydrolytically into cytotoxic by-products. Cells bind to the
GFOGER domain through integrins α1β1, α2β1, α10β1, and α11β1 [11]
(Fig. 1). To increase the bioactivity of collagen hydrogels, researchers
have used them in conjunction with growth factors (GFs) e.g.
BMP-2-soaked collagen hydrogel scaffolds for bone regeneration. GFs are
proteins involved in many cellular processes and intercellular commu-
nication. They can induce cell proliferation, maturation, and differenti-
ation [12]. However, collagen has limited GF binding properties
compared with other ECM proteins such as fibronectin or laminin [13].
Thus, research has focused on various novel methods to overcome this2
obstacle.
In this article, we will overview the various techniques used to pro-
duce collagen hydrogels with varying mechanical and degradation
properties for different tissue engineering applications. We will explore
the different collagen-based, hydrogel GF delivery systems that re-
searchers have developed in recent years and the successful in vitro and in
vivo experiments that have been achieved with collagen hydrogels. GF
delivery has only recently been explored empirically and through
mathematical modeling, particularly in conjunction with mechanical
properties, and has immense potential use in biomaterials in tissue
regeneration. Mechanical property optimization and GF delivery are of
major importance in achieving tissue regeneration, thus it is important to
review them in detail. Extensive reports on collagen hydrogel systems
with and without GFs cannot be found in literature yet. Given that
collagen is an important biomaterial used extensively in tissue
S.O. Sarrigiannidis et al. Materials Today Bio 10 (2021) 100098engineering, this article is important in guiding future research in the
field.
2. Mechanical considerations of collagen hydrogels
Biomaterial selection for a particular application often requires me-
chanical properties of constructs similar to the tissue where they are
implanted, as stiffness is known to determine cell behavior through
mechanosensitive cell receptors. Despite their advantages, collagen's
rapid degradation rate (hence weak mechanical strength), opacity or
high shrinkage have limited its extended application for tissue engi-
neering [14,15] also affecting clinical usability in tissues, which may
require higher stiffness, like bone or cartilage. To give an example
post-treatment or cross-linking of collagen hydrogels can increase the
stiffness of the matrices, stimulating mesenchymal stem cell (MSC) dif-
ferentiation into osteogenic lineages, which has been proposed to occur
at Young's modulus above 25 kPa from atomic force microscopy (AFM)
measurements [16]. The formation of additional cross-links in hydrogels
prevents collagen molecules from sliding past each other under stress
[17]. This increases the mechanical properties of the cross-linked
hydrogels, in terms of tensile, compressive, and shear elastic moduli [17].
Cross-link density, apart from the strength of the cross-links or presence
of multifunctional groups, is thought to be a major contributor to
collagen matrix stiffness [18,19]. Modifying the mechanical properties of
a hydrogel in a single direction, thus creating anisotropic hydrogels, can
also be critical to foster tissue growth in a preferred direction in appli-
cations like neural tissue regeneration or angiogenesis [20,21]. The
combination of natural-based hydrogels with adjuncts that can enhance
their mechanical properties, such as nanoparticle loading (which in-
cludes graphene nanoparticles, Au, dendrimers), or combining with
synthetic fibers or 3D scaffolds (PCL, PGA, etc.) are another fundamental
approach for increasing the mechanical properties of soft hydrogels. The
reader can consult the comprehensive reviews by Thoniyot et al. and
Tozzi et al. [22,23], and more recently Fathi-Achachelouei et al. [24],
where several examples of collagen hydrogels and their combination
with nanoparticles or with solid scaffolds are included. It is also impor-
tant to consider hydrogel degradation in the presence of metal-
loproteinases including collagenase, that are found in native tissues, as it
can also give valuable information about the expected mechanical stiff-
ness once the hydrogels are implanted. The usual concentration of
collagenase used in vitro lies between 0.1 and 5 U/ml, although this may
depend on the final intended application of the hydrogels [25–28]. The
modulation of collagen hydrogels' mechanical properties can therefore
expand their applicability to a wider range of in vitro and in vivo appli-
cations (summarized in Table 1).
The basic mechanical testing techniques used for polymeric materials,
including hydrogels and collagen matrices in particular, include shear
rheometry, (confined) compression, tension, or dynamic mechanical
analysis [29]. Determining a value for the stiffness of the scaffold must be
defined in terms of the type of deformation used by the technique (shear,
compression, or tensile) and, consequently, comparisons should be made
with caution in techniques using different deformation regimes. Collagen
is a non-linear viscoelastic material; therefore, differences in the
time-span or strain used during measurement acquisition can also in-
fluence the final value [8]. Swelling ratio measurements can also provide
information about the nature, degree, and density of cross-linking in the
polymer matrices and can be used to obtain indirectly the mechanical
properties of the gel such as the Young modulus (E) [30]. A widely used
molecular theory that describes the swelling of polymers in a solvent is
the equilibrium swelling theory of Flory and Rehner, by which it is
possible to associate swelling measurements with mesh size (ζ), degree of
cross-linking (MC), or elasticity modulus (E) of the hydrogel [31]. The
theory, although initially developed for vinyl polymers and rubber-like
materials, is applicable to fully swollen, isotropic networks, and in
particular for biopolymers as demonstrated by Lin et al. [32], having3
been used in several systems with semiflexible chains, including collagen
[33–35]. Furthermore, Marmorat et al. observed a good agreement of
theoretically derived mesh sizes with cryo-SEM measurements for
gelatin, a derivative of collagen [36].
Other models have been specifically used to computationally
explain the mechanics of semiflexible polymer networks like collagen
hydrogels and are able to predict the storage moduli of entangled or
cross-linked collagen hydrogels from network parameters [37–39]. One
of the most widely used models is the MacKintosh model [40,41], which
considers biopolymer filamentous structures as worm-like chains, with a
stretching modulus, μ, and bending modulus, κ. The storage modulus is
predicted to scale as G0 ~ κ7/5(c0⋅l)11/5, where κ is the bending modulus,
c0 the concentration of filaments, and l the contour length of the chain
[37,40]. Instead of constructing an analysis using artificially generated
networks, Stein et al. developed a model from real network properties
obtained from confocal microscopy, where the collagen fibers are
considered elastic beams that resist stretching and bending and each
cross-link is treated as a torsional spring [42]. By contrast, the Morse
model also describes tightly entangled solutions of semiflexible poly-
mers, but where the tangential flow of the filaments is assumed, allowing
cross-links to break and rebuild instead of forming a fixed lattice [43].
The type of cross-linking can modulate the mechanical properties of
collagen networks (and other semiflexible biopolymers) by imposing
angular constraints on the cross-links, which modulate the flexibility of
the biopolymer filaments. The extent of the constraint depends not only
on the strength of the cross-linking bond but also on matrix topology i.e.
mesh conformation [44]. In general, chemical cross-linkers will generate
stronger covalent bonds, generating junctions that are fixed and less
‘floppy’ compared with other non-covalent binding forces. Adding
chemical cross-linkers modifies the micro-mechanical response of
collagen hydrogels under deformation, by limiting the slipping of phys-
ical cross-links between collagen fibers, and thus limiting stress relaxa-
tion typical of biopolymer networks [45]. Cross-linking mechanisms will
also determine the viscoelastic behavior of the network. Mooney's group
recently demonstrated how different combinations of ionic, physical, or
covalent cross-linking in collagen-alginate hydrogels led to distinct
viscoelasticity (evaluated through loss angle from shear rheology), which
was correlated with a distinct expression of immunomodulatory para-
crine markers in seededMSCs [46]. In terms of the effects of cross-linking
in the micro-architecture or pore size, this will also be determined by the
type and degree of cross-linking. Zero-length and low-molecular-weight
cross-linkers (Fig. 3) have a limited impact on changing the pore size of
collagen networks, as they can only react with chemical groups that are
already in close contact, changing the bending rigidity of collagen fibers
(as predicted by the Mackintosh model) [47,48]. Cross-linkers with a
significant chain length, like PEG, can impact the mesh size of nano-
porous hydrogels but will not alter the pore size of micrometer-sized
hydrogel networks [49,50]. The length or molecular weight of the
cross-linker will also determine its ability to interconnect distant chains,
having an influence on the degree of cross-linking, a parameter that has a
deep impact on the mechanical properties of the hydrogel [19].
2.1. Cross-linking mechanisms
2.1.1. Physical cross-linking
Collagen I monomers self-assemble into fibrillar structures that may
cross-link and/or entangle to form viscoelastic gels with varied network
structures and mechanical properties in a process known as fibrillo-
genesis, that is generally accompanied by an increase in turbidity [51,
52]. The fibrillogenesis curve has a sigmoid shape with a lag phase in
which aggregation of collagen dimers and trimers in a linear-staggered
with 4.4D periodicity occurs, accompanied by a growth phase where
lateral aggregation of fibrils results in the abovementioned increase of
turbidity [52,53].
The basic structure of collagen type 1 is modified at the post-
translational level, which can have an important effect on mechanical
Table 1
Collagen hydrogel cross-linking systems and their resulting properties: summary of the main parameters examined, which resulted in varying mechanical properties of
the hydrogels and their in vivo/in vitro behavior.
Mechanism of
cross-linking
Parameters varied Network properties SEM: Scanning
electron microscopy TEM:
Transmission emission microscopy
CRM: Confocal reflectance microscopy
MPM: Multiphoton microscopy
Mechanical properties In vitro/In vivo studies References
Physical cross-linking
Fibrillogenesis Collagen concentration N/A Shear moduli Cytotoxicity, enhanced endothelial/
osteogenic differentiation, morphology of
dental progenitor stem cells by combining
soft and stiffer hydrogel.
[78]
N/A Shear moduli Dorsal root ganglia seeding, increased






Fibril width and volume fraction (CRM) Gelification rate, turbidity,
shear, compression and
tensile moduli
MSC differentiation, adipocyte proliferation
at a stiffness of 45 Pa or osteogenesis
(calcium nodules) at 700 Pa
[76]
pH Fibril width (SEM) Relaxation moduli,
compression test
Focal adhesions (actin, vinculin), wider
endothelial cell network formation in rigid
gels
[66]
Temperature Fibril width (MPM, SEM) Shear moduli (rheology) No [65]
Fibril width, pore size (CRM, SEM) Shear moduli (rheology) Greater stiffness/larger pore size promotes
cell contractility, local matrix remodeling,
and differentiation into proangiogenic
myofibroblasts.
Lumen formation was only observed in cold
























Fibril width (SEM) Turbidity, tensile moduli,
ultimate tensile stress,
compressive moduli
Cytotoxicity of porcine smooth muscle cells [64]




Increased neuronal growth and neurite
elongation in aligned gels
[85]
Fibril width (bright field) Tensile moduli Myoblasts aligned with collagen fibrils [95]
Fibril orientation (CRM), optical
transmittance
Viscosity Different keratonocyte fate depending on
degree of alignment in vitro. Similar fibril





Fibril orientation (CRM) Shear moduli LIVE/DEAD, neurite growth and
orientation, electrophysiological activity
[89]
Increased myotube formation in low
stiffness matrices; accelerated muscle
function recovery in rat laryngectomy mode
[92]
UV cross-linking UV cross-linking time Contraction rate Tensile strength Keratinocyte proliferation similar to GA
cross-linking
[109]








Enhanced gene expression levels for the












Cross-linking degree Tensile moduli, elongation
at break
No [136]
N/A N/A Shear moduli Carrier of tendon stem cells supported
TSPCs survival, proliferation, and metabolic















Good adherence and spreading of corneal
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Table 1 (continued )
Mechanism of
cross-linking
Parameters varied Network properties SEM: Scanning
electron microscopy TEM:
Transmission emission microscopy
CRM: Confocal reflectance microscopy
MPM: Multiphoton microscopy





Degree of cross-linking (free amino
groups)
Differentiation of chondrocytes within
hydrogel
Fibril size (SEM, TEM) Shear moduli, degradation Fibroblast-seeded dermal equivalents
showed greater viability in less cross-linked
gels; cross-linked full-thickness skin
equivalents are capable of recapitulating the





N/A Shear moduli, compression
moduli, swelling,
degradation
Good non-cytotoxicity and attachment of




Triple helix structure (circular
dichroism analysis)








Fibril density (CRM) Shear moduli Glycated gels showed increased cell







Survival of smooth muscle cells at 4 weeks in
tunica media equivalents
[125,156]
Fibril width, orientation (CRM) Gelification time,
turbidity, compression
moduli
Viability, proliferation, and attachment of
endothelial cells. Increased matrix stiffness






Fibril width (SEM) Shear moduli, degradation,
swelling
Greater MSC and NSC viability in less cross-
linked gels
[161]
Cross-linking degree (TNBSA) Gelification rate, turbidity,
shear moduli
MSC proliferation at all concentrations, as
well as axonal growth in seeded dorsal root
ganglia
[167]
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strengthens the collagen fiber is the hydroxylation of lysine residues
within the collagen chains [54]. Hydroxylysine (hydroxylated lysine),
together with telopeptidyl lysine, is essential in cross-linking tropocol-
lagen molecules and collagen fibrils. Most hydroxylysine residues can be
found in the collagen's telopeptides rather than the triple helix region
[54]. The action of cross-linking is triggered by lysyl oxidase (LOX),
which converts hydroxylysine and telopeptidyl lysine into hydrox-
yallysine and allysine (aldehyde) [55]. The spontaneous condensation of
aldehydes with lysine and hydroxylysine form immature divalent
cross-links which, in the body, mature intomultivalent cross-links such as
pyridinoline (PYD), deoxypyridinoline (DPD) [56], pyrrole [57] (bone),
or dehydro-hydroxylysinonorleucine (deH-HLNL) (skin) [58]; the exact
maturation process is complex and poorly understood [59]. Collagen
hydrogels are manufactured with both atelocollagen (e.g. pepsin diges-
ted) and soluble telocollagen (e.g. acid-soluble). Acid-soluble telocolla-
gen retains its telopeptides. Thus, tropocollagen molecules can
self-assemble into fibrils, which form further cross-links with each
other involving the lysine, hydroxylysine, and aldehyde residues mainly
found within the telopeptides [58,60]. This stabilizes the collagen
hydrogel and increases its mechanical properties [59]. On the other
hand, pepsin-digested atelocollagen, which lacks telopeptides, forms fi-
brils and interfibrillar cross-links less effectively without the addition of
non-collagenous molecules or further treatment [58].
Varying parameters including collagen concentration, ion content,
anisotropy, isoelectric point (pI), pH, and temperature can alter gelation
kinetics, stiffness, and the nanoscale fibrous architecture of the collagen
hydrogels (Fig. 2). An excellent recompilation of the experimental studies
that have used these parameters to modulate collagen hydrogel micro-
structure and mechanical properties can also be found in Antoine et al.
[8].
2.1.1.1. pH and salt concentrations. Several studies have investigated the5
effects of changes in pH on the rate of fibril formation and morphology of
collagen fibers [51,61]. The fibril diameter obtained from changes in pH
ranges from 80 to 220 nm [51,61]. The fastest rates of fibrillogenesis
occur between pH 6.9 and 9.2, with no significant changes in fibril di-
ameters as seen in transmission electron microscopy (TEM), while gels
formed at more acidic pH showed thicker fibrils and weaker strength
[51]. Collagen has an isoelectric point (pI) of 9.3 in the absence of other
electrolytes [51]. When pH approaches the pI, and at more basic pH, the
surface charge of collagen monomers is reduced, resulting in increased
hydrogen bonds between the triple helix. This minimizes the electrostatic
repulsion between fibrils because of the increase of the triple helix sta-
bility, thus favoring collagen molecule aggregation [61,62].
It is generally recognized that collagen gels formed at a pH of 6 or
lower have thicker fibers but are less densely packed than hydrogels
formed at higher pH, being also softer. Such pH effect has been exploited
for tissue engineering applications by several authors, after previous
mechanical characterization with shear, tensile, or compressive tests
showed higher moduli gels formed at slightly basic pH [63–65]. Yama-
mura and colleagues varied the stiffness of collagen gels of a fixed con-
centration by modifying the pH between 5 and 10 to study the formation
of microvessel networks [66]. Relaxation modulus, as measured by uni-
axial compression tests, was 4.6 times higher in their most alkaline
composition compared with gels at pH 5, plateauing at 20 kPa at pH 8.
Despite forming thinner fibrils in pH > 8 hydrogels, these are more
densely packed, increasing the relaxation moduli. Endothelial cell
migration was hindered in rigid gels, but the formed microvessel net-
works were thicker and deeper [66]. A similar approach was undertaken
by Chung et al., but gelifying 2 mg/ml type I collagen gels inside a spe-
cifically designed microfluidic platform for introducing vascular endo-
thelial growth factor (VEGF) gradients, and varying the pH between 7
and 11. The low pH, soft collagen composition showed thick collagen
fibers with large pore size, while the high pH collagen has thinner fibers
and smaller pore size, inducing different angiogenic behaviors [67].
Fig. 2. Physical cross-linking mechanisms of
collagen hydrogels. 1: Showcases the parame-
ters that affect collagen fibrillogenesis namely a)
pH – collagen fibers become thinner and denser
as pH increases b) collagen concentration –
collagen fibers become denser as concentration
increases and c) orientation – fibers can be
organized directionally through magnetic and
electric fields or a specialized mold. 2: Outlines
the further physical cross-linking mechanisms
used when designing collagen hydrogels. a)
Dehydrothermal treatment (DHT) takes advan-
tage of heat under vacuum to create amide bonds
in collagen hydrogels and b) UV irradiation that
binds histidines with hydroxyl groups.
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mechanical properties of collagen gels, and the relationship with their
microstructural architecture, providing background to develop novel
strategies for tissue repair [68]. Collagen hydrogels of 2 mg/ml poly-
merized at normal physiologic pH 7.4 had a linear modulus and failure
stress of 16.6 and 6.0 kPa in uniaxial tension tests, respectively. In
addition, matrices formed under increasingly acidic conditions showed a
progressive decrease in mechanical properties, with basic gels being
stiffer. Confocal microscopy showed how gel fibers under acidic condi-
tions were not only thicker and less densely packed but also shorter
compared with the stiffer basic gels.
Testing of different pH conditions has also been performed to eval-
uate the 3D-printability and suitability of fibroblast and keratinocyte-
laden cells as skin engineering substitutes [69]. Collagen hydrogel scaf-
folds were printable at pH 5, 6, and 7, although only the latter was
considered suitable for seeding with cells because it showed limited
swelling. The gels showed good cell viability despite their low stiffness
(20 Pa) measured by compression [69]. Nevertheless, there exists the
concern that changing pH of the scaffold can affect cell viability if not
maintained within the range 7.4–8.4 in applications involving cell
encapsulation. We note that allowing cell invasion after the hydrogel is
formed would involve degradation of collagen due to reduced pore size6
[10]. The ionic strength of the buffer used to dissolve collagen will also
affect the final mechanical properties of the collagen hydrogels. Presence
of different ions and their concentrations have a strong impact on the pI
of collagen and will influence its net charge and the interactions between
collagen chains [70]. Wood et al. already identified how increasing NaCl
(thus ionic strength) in a NaOH–KH2PO4 buffer had a similar impact as
decreasing the pH, by increasing the most frequent fibril size from 90 to
250 nm, although mechanical properties were not measured [51].
Changes in ionic strength lead to changes in fibril diameter, suggesting
that lateral growth of collagen fibrils during fibrillogenesis also involves
electrostatic interactions [71]. In terms of structural properties, increased
ionic strength reduces the pore size and leads to a slower gelation kinetics
[72]. Achilli et al. observed that increasing the ionic strength of collagen
gels at specific conditions (pH 10 and polymerization temperature of 4
C) could significantly increase the mechanical properties of the gel
without affecting viability of cells seeded on top [64]. Typically, collagen
hydrogel protocols use not only PBS10x as concentrated buffer but also
others like (D)MEM10x, M19910x, and HBSS10x have been used [8].
2.1.1.2. Collagen concentration. Collagen concentration is another
parameter that can easily be modified to tune hydrogels’ stiffness by
Fig. 3. Chemical cross-linking mecha-
nisms of collagen hydrogels. 1: Zero-length
cross-linking using N-(3-Dimethylamino-
propyl)-N0-ethylcarbodiimide (EDAC) or
dicyclohexyl carbodiimide (DCC) as well as
an N-hydroxysuccinimide (NHS)-Ester to
form bonds between the carboxyl and amine
groups of collagens. EDAC or DCC reacts
with a carboxyl group to create a reactive
intermediate (o-Acylisourea), which then
reacts with an amine group to form a cova-
lent peptidic bond. This reaction can be
catalyzed by introducing an NHS–ester,
which forms a more stable intermediate. 2:
Linear cross-linking of collagen can occur
through various reactions. a) Glycation,
where a reducing sugar such as glucose in-
teracts with an amine group to form a Schiff
base. The complex reorganizes into an
Amadori product and then a reactive inter-
mediate, which can react with other amine
groups to form complex cross-links such as
pentosidine. b) Genipin interacts with amine
groups and then forms cross-links by binding
to adjacent-bound genipin molecules. c)
Glutaraldehyde (GA) or hexamethylene
(HDMI) bind amine groups on each side
group of their carbon–carbon chain to form
cross-links. d) PEG can be produced with 4
(depicted), 6, and 8 (depicted) arms (3.) to
create branched cross-links, and its cross-
linking chemistry will depend on the moi-
eties of its end-groups. Some types of PEG
used to cross-link collagen are PEG succini-
midyl glutarate (3.i) which binds amine
groups of collagen and PEG acrylate, which
can bind to collagen PEGylated with PEG
acrylate when using UV with a photoinitiator
(3.ii).
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inversely proportional way with concentration [37,45,63,74], except
when under non-linear, high-stress deformation regime [47]. At the same
time, an increase in collagen concentration does not result in an increase
in fibril diameter [7,51,68] but in reducing the pore size of the fibrillary
network [51,72]. Increasing concentration does not generally affect fibril
diameter, which lie on the range between 270 and 290 nm [51,68,75,
76]. Collagen concentration is an easily tunable parameter that has been
used in a wealth of translational and in vitro studies.
Current studies tend to use collagen concentrations higher than 1 mg/
ml as the resulting gels are easier to handle, can reach higher stiffness
values and also for biological considerations, considering the concen-
trations found in native tissues. Rylander et al. produced gels of 4, 6, 8,7
and 10 mg/ml as these are concentrations commonly found in tissues in
vivo [63]. In their study, they recognized the complex interplay between
pH, concentration, and gelification temperature to obtain hydrogels of
stiffness that can simulate different tissues, proposing an automated
formula to determine, which conditions can produce a target modulus.
The model was validated by matching collagen gels at pH 7.4 and 8 to
match normal (2000 Pa) and cancerous (4000 Pa) human breast tissue
both within their compressive moduli range between 540 Pa and 10,700
Pa and pore sizes from 1.2 to 3.2 μm [63]. Willits et al. developed gels
between 0.4 and 2 mg/ml and measured their elastic moduli in a
rheometer, obtaining 2.2 Pa for the gels prepared at the lowest concen-
tration, and 17 Pa for the highest concentration. They found the
maximum neurite growth from dorsal root ganglia (DRG) at the lowest
S.O. Sarrigiannidis et al. Materials Today Bio 10 (2021) 100098collagen concentrations, so that the mechanical stiffness seemed to
hinder neurite growth [77]. Overall, increasing the collagen concentra-
tion will result in a slight increase in strength, which can be amplified by
adjusting other parameters like pH, but will also restrict cell migration
and nutrient diffusion [15].
Pankajakshan et al. describe a modular collagen construct for dental
pulp regeneration, consisting of central core of soft (285 Pa) collagen
simulating the inner root canal, and an outer layer of stiffer (800 Pa)
hydrogel interacting with the surrounding dentin. Stiffness was
measured as shear storage moduli (G0) and varied by using a concen-
tration of 1.37 mg/ml for the soft gel and 2.88 mg/ml for the stiffer one.
VEGF was incorporated into the soft inner core and BMP-2 in the outer to
foster endothelial proliferation/vasculogenesis and odontogenic differ-
entiation of encapsulated dental progenitor stem cells, respectively. The
combined effect of mechanical stimulation and GF delivery was further
investigated in vivo (Fig. 4) [78]. Collagen concentration also has an in-
fluence in cell motility, as a result of the change in mesh size. A reference
study by Saltzman and Parkhurst used collagen rat tail concentrations
between 0.1 and 0.7 mg/ml to study neutrophil motility in collagen
matrices. They first mathematically modeled cell motility was found to
be near Brownian (random) motion inside the collagen gels and esti-
mated the intercollagen spacing at 10 μm (approximately the size of a
neutrophil) for their lowest concentration. In the experimental part, they
identified an optimal concentration of 0.3 mg/ml for cell–fiber in-
teractions with a peak in neutrophil motility, linearly decreasing at
higher concentrations [79]. Also applied to cancer cell motility, Sapudom
et al. studied the influence of pore size, fibril diameter, and elastic moduli
in the capacity of cancer cells to invade and attach to collagen gels with
concentrations 2, 2.5, and 3.5 mg/ml (smaller pore size and greater
elastic moduli at higher concentrations) and also at different pH (which
modifies the fibril size but not the elastic moduli) [74]. Interestingly,
they found increased cancer cell invasion and cluster formation into the
samples with greater fibril diameter but independent of the pore size and
elastic moduli of the gels [74]. This highlights the importance of networkFig. 4. Regeneration model for dental pulp canal using collagen hydrogel
loaded with different growth factors: A. Schematic illustration of model, with
an outer collagen hydrogel of 2.88 mg/ml (800 Pa) containing dental pulp stem
cells (DPSCs) and bone morphogenic protein 2 (BMP-2), and an inner collagen
hydrogel (1.37 mg/ml, 235 Pa) containing DPSC and vascular endothelial
growth factor (VEGF). B. Concentrically injected collagen hydrogels in tooth
transversal slice. C. Interface adaptation between the two matrices evidenced by
reflectance microscopy. Reproduced with permission from Ref. [78].
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properties and microscale mechanics and not just mechanical properties
on cancel cell invasion of ECM-derived scaffolds.
2.1.1.3. Temperature. Gelation temperature has a significant effect on
polymerization kinetics, that will largely determine the mechanical
properties of collagen hydrogels. Fibrillogenesis occurs faster at higher
temperatures due to accelerated nucleation and lateral aggregation of
collagenmolecules [51,53]. With increased temperatures, collagen fibrils
show smaller width [51,53] and are also shorter and randomly aligned
[80,81], forming meshes with smaller, more homogenous pore size [63,
80]. Lower temperatures are thought to limit nucleation of new fibers via
decreasing entropy, which promotes thickening and elongation of
already existing fibers, and forms networks, which are often more het-
erogeneous [82]. In terms of mechanical properties, trends are not so
straightforward, with reports of increased stiffness for denser gels
resulting from higher gelation temperatures (~37 C) [63], whereas
other studies show greater compressive or shear moduli in gels produced
at lower temperatures, e.g. 4 C [64,83]. These discrepancies are thought
to depend on pH and collagen concentration, and possibly on the me-
chanical testing setup [8,63].
Fischbach's group tested collagen hydrogels polymerized at 4, 20, and
37 C to obtain gels of distinct microstructure and mechanical properties
for myofibroblast differentiation and vasculogenesis [82,83]. In their
first study, the authors verified experimentally and computationally that
quick gelation at 37 C yielded networks with thin fibers and small pores,
whereas hydrogels at 4 C showed thicker fibers and larger pores that
were also stiffer under shear deformation [83]. They observe that the
greater stiffness/larger pore size promotes cell contractility, local matrix
remodeling, and changes in mechanosignalling stimulating ASC differ-
entiation into proangiogenic myofibroblasts. The same hydrogels are
tested in the second study with human cerebral microvascular endothe-
lial cells and human umbilical vein endothelial cells (HUVECs) to eval-
uate microvessel formation. Hydrogels were polymerized at 4 or 37 C
and compared with the same compositions combined with Matrigel, a
gelatinous ECM-derived material used in several biological applications
[82]. Matrigel alters the microstructure of the hydrogels producing wider
fibrils, and possibly larger pore size although this parameter was not
measured. Fibronectin, laminin, entactin/nidogen-1, and perlecan found
in Matrigel interfere with collagen fibrillogenesis by providing collagen
nucleation sites [84]. Lumen formation was only observed in cold cast
hydrogels mixed with Matrigel, and vascular networks were more
branched in this composition, attributed to the microstructure triggered
by gelation at 4 C and the combination with Matrigel [82]. Achilli et al.
evaluate temperature as one of the parameters tuned during hydrogel
synthesis, also for vascular applications by seeding smooth muscle cells, a
component of vascular structures [64]. The improvement of the me-
chanical properties of the gels prepared at 4 C and at pH 10 was almost
fourfold compared with the gels polymerized at 37 C. Antoine et al.
identified the reverse effect of gelation temperature on mechanical
properties, with a significant positive correlation between temperature
and stiffness, and a compressive modulus of up to 10 kPa using a collagen
concentration of 10 mg/ml and pH 8.4 [63].
2.1.1.4. Fiber orientation. Collagen is a fibrillar protein; therefore, matrix
microstructural anisotropy and alignment can affect to a great degree its
mechanical properties and cell organization [85]. In regeneration of
certain tissues such as nerves and corneas, the alignment of collagen fi-
brils in hydrogels to guide cells and tissues is vital to regulate the
migration, orientation, and shape of grafted cells [6]. Aligned constructs
fail at lower strain but higher stress values than those with more random
fibril organizations and consequently can bear more load. An example of
this is tendon, whose aligned fibers shown tensile moduli of 43–1600
MPa whereas dermis, where collagen fibers show more random orien-
tation, is 21–39 MPa [73]. Several methods have been reported to ach-
ieve collagen fiber orientation in hydrogels, including topography in
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electrochemical fabrication [90], continuous or cyclic stretching [85],
extrusion and bioprinting [21,91–93].
Collagen hydrogels capacity for fibril alignment and tensile properties
have been exploited in muscle and vascular regeneration applications.
Cummings et al. produced aligned collagen vascular constructs of high
stiffness by cyclic straining, with a tensile modulus of 200–250 kPa that
allowed endothelial cell proliferation [94]. Another study reported an
80% increase in tensile Young's modulus (13.4 9.6 kPa) compared with
measurements along the perpendicular direction in myoblast-seeded
collagen gels aligned by acoustic patterning [95]. The authors later
showed how collagen effectively maintained the viability of the cells as
they shifted from a rounded morphology into adherent myoblasts, which
contracted the aligned gels while retaining the patterned configuration.
Brookes et al. fabricated tissue-engineered aligned muscle constructs by
polymerizing rat-tail collagen type I encapsulating C2C12 and muscle
progenitor cells inside a cylinder under constant flow [92]. The con-
structs showed fibrillary and cell alignment in comparison with standard
polymerization methods. The authors found more extensive myotube
formation for constructs prepared at high cell densities (107 cells/mL)
within low stiffness matrices (200 Pa) and investigated it further in
laryngeal rat partial laryngectomy models.
Fiber alignment is especially critical in some specific applications like
nerve regeneration, and collagen has enabled significant progress in the
field. In very early studies, Tranquillo's group described how magneti-
cally aligned collagen gels, thanks to the diamagnetism of the peptidic
bond initially described in 1984 [96], stimulated and directed neurite
elongation and Schwann cell invasion in DRG [20,88]. More recently,
Antman-Passig et al. produced mechanical orientation of collagen gels by
uniaxial cyclic stretching using glass capillaries [85]. The gels had a
comparatively low mechanical strength (shear moduli of 140  30 Pa),
but fibrillar orientation was enough to induce increased neurite elonga-
tion in DRG, primary neurons, and neuron-like pheochromocytoma
PC12 cells in comparison with randomly aligned gels. Orientation of
collagen fibrils is also crucial for corneal regeneration. Kim et al. printed
in an extrusion-based bioprinter collagen seeded with keratinocytes with
needles of different diameter. In the smallest diameters tested (25 and 30
gauge), for which greater shear forces were applied, aligned cells were
observed along the direction of the printing path and had higher
expression levels of the keratocyte-specific genes and keratocan than
those of the other groups. Keratocytes also produced more collagen I in
the aligned gels, indicating that collagen fibrils provide a stroma-like
environment. Matrix remodeling was also associated with 45% higher
transparency compared with non-aligned control hydrogels [97].
A special case of collagen alignment procedure is plastic compression,
which consists on subjecting dilute collagen hydrogels to known loads,
expelling >80% water from the gel and aligning fibers in the direction of
water removal [98,99]. Plastic compression causes fiber densification
and significantly increases the mechanical properties of gels without
inducing significant cell death, and has been used to engineer skin sub-
stitutes [100], artificial corneas [101], articular cartilage [102], or arti-
ficial laryngeal cartilage [103].
2.1.1.5. UV cross-linking and dehydrothermal treatment. Collagen can be
cross-linked using other physical methods that do not take place
naturally in vitro, by using external physical factors that induce
chemical cross-links between collagen fibers. Although UV cross-linking
and DHT induce partial collagen denaturation, they are successful in
modulating the mechanical properties and microstructural organization
of collagen hydrogels. DHT is a cross-linking method known since the
1960s, where collagen carboxylic acid and amino side chains are cross-
linked via condensation in a vacuum oven [104]. DHT is more commonly
used in membranes, fibers, and scaffolds as it involves complete drying of
the samples subjecting to temperatures of >90 C, [105–108]. UV
cross-linking produces free radicals on tyrosine and phenylalanine9
residues that cross-link collagen [109]. It is much faster than DHT,
reducing cross-linking time from days to minutes [110]. Irradiation doses
up to 500 Gy have been reported to increase storage modulus up almost
150% [111], nevertheless other authors have documented a reduction of
stiffness with increased UV irradiation time, possibly associated with
degradation of collagen matrix [109]. In the same study, the combined
use of UV cross-linking and DHT showed increasedmechanical properties
while cell proliferation was not negatively affected. Riboflavin, a
photosensitizer that generates a singlet oxygen, has been used to aid
photo cross-linking of collagen and tested for meniscus tissue engineering
applications [112]. Adjuvant use of riboflavin in UV cross-linking in-
creases the Young's modulus of 3.5 mg/ml rat tail collagen hydrogels
from 150 to 600 kPa with 45–60 min irradiation, while hydrogels that do
not contain riboflavin are degraded with increased irradiation time
[113]. The UV/riboflavin cross-linking procedure is actually used by
ophthalmologists in a procedure called corneal cross-linking for the
treatment of ketatoconus, a condition in which the central area of the
cornea becomes thinned [114].
2.1.2. Chemical and enzymatic cross-linking
Covalent cross-linking of collagen hydrogels is commonly used in
drug delivery and tissue engineering applications to control in vivo ab-
sorption of collagen and to increase the mechanical properties of the
material. In physiologic conditions, stabilization of fibrils is reinforced by
means of cross-linking by condensation of lysine and hydroxylysine
residues and aldehyde formation, a reaction catalyzed by the enzyme
lysyl oxidase. This mechanism provides the collagen fibrils with higher
tensile strength, necessary for tissue integrity [115,116].
In the introduction of this section, we have already described how
different type of cross-linkers can impose angular constraints in the cross-
links reducing the flexibility of the collagen fibers [44]. Some of the most
commonly used cross-linking agents are glutaraldehyde, carbodiimides
(e.g. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide – EDAC). [117,
118], chromium tanning [119], formaldehyde [120], polyepoxy com-
pounds [121], acyl azide [122], hexamethylene diisocyanate (HMDI)
[123,124] carbohydrates e.g. (ribose [125], glucose [126]), and plant
extracts, especially genipin. Many of these cross-linking methods have
also been reviewed for collagen fibers but not hydrogels [127]. Recently,
the influence of polyethylene glycol (PEG) polymers that can vary in
molecular weight, degree of branching, and terminal groups have been
intensively evaluated for cross-linking and functionalization of
collagen-based devices [126,128–130] (Fig. 3). Branched cross-linkers
increase the number of fibers that meet at each network junction, known
as local connectivity (z) of the network, contributing also to the me-
chanical stability of the hydrogel [39].
2.1.2.1. Glutaraldehyde. Glutaraldehyde (CHO(CH2)3CHO) is a bifunc-
tional cross-linking agent, which forms monomeric or oligomeric cova-
lent bonds between two amino acid side chains, typically lysyl and
hydroxylysil residues within collagen [131]. Glutaraldehyde and its
shorter-form formaldehyde (HCHO) are extensively used as fixation
agents for bacteria, cells, or tissues [132], but they are far from ideal for
hydrogel cross-linking because their bonds are transient and sustained
release of monomers over time is cytotoxic [133]. Glutaraldehyde at low
concentrations was among the first studied cross-linkers for collagen and
for scaffold cross-linking [131,134,135]. Nowadays, however, glutaral-
dehyde is mainly used as control cross-linking molecule, to compare the
degree of cross-linking or amount of free amines with respect to other
cross-linking methods, due to the fact that glutaraldehyde is an active
cross-linker that can react with virtually any amine group in collagen
[118].
2.1.2.2. Hexamethylene diisocyanate. Isocyanates are another versatile
cross-linkers for collagen hydrogels. HMDI was initially studied as a
possible alternative to glutaraldehyde to cross-link collagen scaffolds in a
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HMDI and amines in the collagen molecule generates cross-links con-
taining stable urea groups [137]. The low solubility of some isocyanates
in water means a surfactant is needed to promote the reaction with free
amine groups. Isocyanates are strong, linear cross-linking agents that can
significantly increase the mechanical properties of collagen biomaterials,
including microspheres [123] hydrogels [137], scaffolds [138], mem-
branes [139], or fibers [127]. Butane diisocyanate has been used as
functional group with pluronics to generate a thermosensitive
collagen-butane diisocyanate hydrogel for tendon stem cell delivery,
which showed reduced contraction compared with untreated gels [140].
Currently, the commercially available Collagen Repair Patch from Zim-
mer uses a proprietary isocyanate cross-linking technique [3].
2.1.2.3. Carbodiimides. Carbodiimides such as cyanamide or 1-ethyl-3-
(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDAC or EDC)
are alternative, widely used zero-length cross-linkers that can establish
peptide-like bonds between carboxyl and amino groups in collagen
without becoming a final part of the amine bond [133]. The by-product
of the reaction is a non-toxic chemical, urea and can be washed away
after cross-linking [141]. Cross-linking with EDAC is also attractive for
biomedical applications as it can take place on physiological-like con-
ditions (pH 7.4, 37 C), although its maximum efficiency is at a mildly
acidic pH (4.5). Another important consideration is that although it is
compatible with phosphate buffers, amine containing buffers (e.g. Tris)
should be avoided as they can quench the reaction [142]. NHS is often
used with EDAC to improve efficiency of the reaction by creating
dry-stable intermediates.
EDAC has been extensively evaluated as a cross-linker molecule for
biomedical applications. Yang et al. showed how increasing the con-
centration of EDAC reduces swelling ratio and increases resistance to
enzymatic degradation in 2 mg/ml collagen hydrogels [117]. Authors
report no negative effect in cell adhesion and proliferation. Although
EDAC/NHS is largely considered a biocompatible cross-linking method,
some authors have noted the possible negative effect of reducing the
availability of the carboxylate anion of glutamic acid, which is critical for
cell attachment to collagen. Cross-linking with EDAC/NHS was shown to
modulate both the affinity and the mode of cell interaction with collagen
films, resulting in decreased cellular spreading, survival, and growth
[143]. This can be understood within a general discussion about using or
not cross-linkers, as most of them intervene with cell-adhesive motifs
[144]. Vogel et al. compared non-cross-linked and EDAC-cross-linked
collagen hydrogels with a stiffness of 90 and 160 Pa, respectively, to
assess the osteogenic differentiation of MSCs, which was found for both
conditions after 22 days of culture [145]. Another carbodiimide,
N-Cyclohexyl-N0-(2-morpholinoethyl) carbodiimide metho-p-toluenesul-
fonate (CMC), was evaluated as a substitute for EDAC for corneal appli-
cations [4]. CMC contains two heterocyclic compounds, which reduce
mobility of the molecule and increase its steric hindrance.
CMC/NHS-cross-linked collagen hydrogels exhibit superior tensile
strength, closer to that of human cornea, and decreased elasticity. CMC
hydrogels were also more resistant to collagenase degradation. Both
EDAC and CMC cross-linked hydrogels showed similar corneal epithelial
cell proliferation after 15 days. Carbodiimide chemistry can also be used
to couple collagen with other carboxyl-containing molecules like hyal-
uronic acid [146,147].
2.1.2.4. Polyethylene glycol. PEG has been extensively used as a matrix
for controlled drug and cell delivery, owing to its biocompatibility, non-
immunogenicity, low protein adsorption, and long history of safe in vivo
use, as well as the versatility of its chemistry [14,148]. PEG resists
recognition by the immune system, and its rapid clearance from the body
has permitted FDA approval for several biomedical applications [149].
PEG can have linear or branched structures, and its basic form has end
hydroxyl (-OH) groups, which can be functionalized with other groups10(e.g. acrylates, azides, maleimide) for different kinds of cross-linking
[148]. An improved utilization of PEG is through star polymer structures:
three-dimensional hyperbranched structures in which linear arms of
different molecular weights stem from a central core. Star polymers may
be used in a variety of biomedical applications because they provide a
high density of functional groups in a small volume and are thus
attractive as drug delivery carriers [150].
PEG in its various forms enables enhanced tunability for mechanical
optimization of the collagen gels, without affecting cell viability.
Branched PEG can have a more radical effect on the mechanical prop-
erties even at low concentrations. In a thorough study, Lotz et al. used
four-arm polyethylene glycol succinimidyl glutarate (PEG-SG) at two
different cross-linking ratios, 50% and 100%, obtaining an Young's-
modulus of 557 and 1225 Pa, respectively, while the non-cross-linked
control did not surpass 320 Pa [50]. Collagen hydrogels exhibited fast
degradation on collagenase digestion, whereas semi-cross-linked PEG-SG
maintained 35% of the initial mass, which was increased up to 60% for
fully cross-linked hydrogels. In terms of microstructure and pore size, the
fully cross-linked gel led to hydrogels with a visibly denser network in
comparison with semi-cross-linked gels, and no fibril-like structure for-
mation. Both 50 and 100% cross-linked hydrogels showed inhibited
shrinkage in comparison with native fibrillar collagen gels. Finally, all in
vitro skin models based on both cross-linked and non-cross-linked
hydrogels formed a multilayered epidermis and similarities to human
skin. Sargeant et al. compared cross-linking collagen four-arm to
eight-arm PEG SG, which is expected to further decrease the pore size and
increase the stiffness of the hydrogels. Indeed, the compressive modulus
was significantly higher for the eight-arm PEG formulations compared
with those with four-arm PEG-SG, reaching 20 kPa [151]. Overall, the
hydrogels composed of eight-arm PEG exhibited minimal swelling/-
shrinkage (less than  5 wt.%), while the hydrogels composed of four--
arm PEG swelled in excess of 100 wt.%. It is worth noting though that
neither the molecular weight nor the collagen concentration (which was
in the high 50–100 mg/ml range) were kept constant in both conditions,
which may affect interpretation of the results. The gels were equally
non-cytotoxic and allowed fibroblast proliferation. Taguchi et al. evalu-
ated as well the cytotoxicity of PEG-SG cross-linker with an alkalized
collagen gel prepared at a 4S-PEG concentration of 1 mM for cell
encapsulation by histology and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) cytotoxic assay after 2 days [128]. Other
functionalizations and degrees of branching have been used based on the
PEG molecule. Cosgriff et al. tested PEG-diacrylate cross-linker for the
stabilization of bacterial collagen hydrogels. The presence of acrylates
allows for photo-cross-linking with an appropriate photoinitiator. The
authors showed that the PEG conferred much of the mechanical strength
to the hydrogels, obtaining compressive module values of around 140
kPa at 6 mg/ml of collagen concentration [129].
2.1.2.5. Glycation. Non-enzymatic glycation has also gathered interest
as a cross-linking method for collagen [152,153]. Collagen cross-linking
by glycation or glycosylation is a pathologic process occurring in vivo,
accelerated in mammalians during aging or in conditions like diabetes.
Reducing sugars covalently bind to free amine groups and establish
cross-links with ECM proteins and with other glucose-modified proteins
(the so-called advanced glycation end-products) [154,155]. An advan-
tageous characteristic of glycosylation as a cross-linking mechanism is its
capacity to alter the mechanical properties of collagen gels with
non-toxic molecules like glucose or ribose. Increasing concentration of
glucose-6-phosphate (G6P) has been shown to reduce degradability of
collagen hydrogels by collagenase without affecting cell viability [156].
Incubation of collagen with G6P has also been shown to inhibit gel
contraction by cells in a concentration-dependent manner [155].
Glycosylation has therefore been studied as a potential cross-linking
method for plenty of tissue engineering applications. Roy et al. used
collagen type I hydrogels pre-incubated with 250 mM ribose, showing a
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to encapsulate chondrocytes [152]. The authors found increased
glycosaminoglycan (GAG) and collagen endogenous production in com-
parison with standard collagen gels after 4 weeks. In early studies,
Tranquillo's lab reported that incubation of collagen type I tunica-media
coronary equivalents with 30 mM ribose for 10 weeks increased the
circumferential tensile strength and moduli with respect to controls
[125]. Encapsulated smooth muscle cells induced circumferential align-
ment of collagen fibers, which was necessary together with
glycation-based cross-linking to producematrix stiffening. As a result, the
vascular equivalents closely recapitulated the non-linear stress–strain
curves of a rat aorta. Another study by Mason et al. reported an increase
of compressive moduli in 1.5 mg/ml gels from 200 Pa in the non-glycated
gel to 700 Pa in the gels incubated with 250 mM ribose [157]. The au-
thors also showed that endothelial cells (ECs) remain viable and prolif-
erate after 3 weeks of culture, showing that glycation does not alter EC
viability and proliferative potential. In addition, endothelial cell spher-
oids cultured on the stiff, glycated gels showed a twofold increase in the
total extension length per spheroid and a 1.5-fold increase in the average
number of extensions. The participation of glycation cross-linking in
pathologies like diabetes or in tumor progression [158], together with
the documented effects of advanced glycation end-products on stem cell
turnover [159] may limit its applicability for tissue engineering appli-
cations, and more studies are needed to dilucidate its effect on cell
adhesion and influence on phenotype expression.
2.1.2.6. Genipin. Several researchers have evaluated other non-
cytotoxic molecules for cross-linking of collagen, finding in natural-
plant extracts like genipin [160–162], procyanidin [163], or oleur-
opein [164] some attractive candidates. Among them, genipin, a natural
cross-linking agent derived from the gardenia fruit, has been among the
most studied [165]. Genipin reacts non-specifically with primary amine
groups to produce a secondary activated form of genipin, and its ester
group forms a secondary amide bond with proteins [166]. The oxygen
radical-induced polymerization of genipin releases blue non-toxic pig-
ments that caused the gels to assume a blue color. Genipin itself is
significantly less cytotoxic than glutaraldehyde, although this is
concentration-dependent [165]. In tissue engineering applications,
Macaya et al. verified that genipin collagen gels possess a high resistance
to collagenase degradation, nevertheless neural stem cell (NSC) viability
after 24 h was decreased up to 60%with 0.25 mM of cross-linker and was
as low as 5% for 0.5 mM [161]. Výborný et al. compared genipin with
EDAC cross-linking in ECM-based hydrogels (composed mostly of type I
collagen) and observed that at the same concentration, genipin had
higher cross-linking capacity (up to 50% using 10 mM) and also led to
stiffer gels as measured by rheology (G’ of 100 Pa compared with 20 Pa)
[167]. Genipin also led to gels less liable to contraction caused by seeded
cells. Cross-linking the hydrogels with a concentration of 5 mM of both
cross-linkers significantly decreased MSC proliferation attributed to
cytotoxicity of unbound cross-linker molecules, while a smaller concen-
tration of 1 mM did not affect proliferation in comparison with non--
cross-linked hydrogels. Such concentration did not seem to negatively
affect NSC differentiation in encapsulated DRGs and was further evalu-
ated in in vivo studies [167].
2.1.2.7. Transglutaminase and other enzymes. Enzymatic cross-linking
with transglutaminase or LOX are other cross-linking methods that create
bonds, which are compatible with cells and naturally present in vivo.
Transglutaminases can form an isopeptidic bond between glutamine and
lysine from different proteins, and its resulting bonds are highly resistant
to proteolysis [168]. A more in-depth review focusing on trans-
glutaminase cross-linking for collagen and other proteins has been pub-
lished [169]. Lee et al. showed that stiffer hydrated collagen matrices
cross-linked with 500 μg/ml of transglutaminase result in increased
endothelial sprouting and obtained lumen-like structures in a11vasculogenesis study [170]. Transglutaminase has been used as a
cross-linker for collagen with a wide range of stiffness for developing
tumor in vitro models with unique properties [171]. LOX oxidatively
deaminates lysine and hydroxylysine residues in the telopeptide domains
of collagen, enabling the formation of cross-links between collagen fibers
to form a 4D staggering [172]. A drawback of transglutaminase and LOX
cross-linking is that they have a limited effect on the mechanical prop-
erties, and in addition, they are cost prohibitive for large-scale or clinical
applications [173].
3. Importance of growth factor loading in collagen-based
scaffolds
GFs are powerful molecules involved in various cellular processes and
often function as the signaling molecules between cells. They cause cell
proliferation, maturation and, at times, differentiation, making these
molecules particularly important for tissue regeneration [12]. The chal-
lenge in using GFs in tissue engineering is to keep them active and stable
within the material for a prolonged period to allow cells to migrate to the
site of injury, proliferate, and differentiate. This requires GF binding sites
that can immobilize, stabilize, and present the GF to cells in a useful
manner as well as release it in a more timely manner into the environ-
ment [12].
Collagen type I, a material often used in tissue engineering, does not
have a high affinity and binding capacity to GFs [175], thus different
strategies have been explored to retain the GFs in scaffolds based on this
natural material (Table 2) (Fig. 5).
3.1. Direct loading
The simplest way to incorporate GFs into a collagen hydrogel system
is to incorporate them directly into the collagen matrix. If no modifica-
tion is made, then the release – governed by diffusion –will likely show a
rapid burst at the start with most of the GF leaking out of the material
[176]. Kanematsu et al. [177] developed a collagen-based hydrogel
formed in solutions of basic fibroblast growth factor (bFGF), hepatocyte
growth factor (HGF), platelet-derived growth factor (PDGF-BB), VEGF,
insulin-like growth factor-1 (IGF-1), and heparin binding epidermal
growth factor-like growth factor (HB-EGF). VEGF, HB-EGF, and IGF-1
exhibited the characteristic burst release profile and substantial loss of
loaded GF. However, HGF, bFGF, and PDGF-BB showed a somewhat
sustained release profiles, which were parallel to the biodegradation
profile of the collagen matrix. Thus, depending on the GF collagen can
function as reservoir suggesting that direct loading should not be dis-
counted as a strategy depending on the GF and application parameters
[177,178].
Collagen–GF interaction can also be enhanced in a pH-dependent
manner. Studies with recombinant human bone morphogenic protein 2
(rhBMP-2) showed that rhBMP-2 binding to collagen could be enhanced
not only by increasing the pH but also by adding NaCl to the carrier
solution. Proton ions likely facilitate the self-association of rhBMP-2 to
form layer on collagen. Thus, rhBMP-2 could be loaded more efficiently
into collagen hydrogels resulting in improved osteoinductive materials
[179].
Collagen–GF interaction is mostly weak, and the release profile of
proteins from the hydrogel matrix is governed by diffusion and steric
hindrance. Hydrogel mesh size can range from the nanometer- [180] to
the micrometer [177]-scale depending on collagen type used, cross--
linking concentrations, temperature, and pH during the hydrogel pro-
duction process [181]. When themesh size of the hydrogel is greater than
the GF/molecule loaded, then the release is primarily affected by diffu-
sion, especially at low GF concentrations. Diffusion is a major mechanism
of GF release from highly porous fibrillar collagen hydrogels, which are
commonly used in tissue engineering. When a GF/molecule is loaded,
particularly when it has low affinity for collagen, rapid release is
observed [182]. This lead researchers to use high concentrations of GF
Table 2
Collagen–growth factor (GF) release systems: summary of their growth factor retention ability and their main benefit.
Mechanism of GF
loading





bFGF 50% after 7 d N/A The affinity of bFGF to collagen was
examined and compared with other
GFs.
[177]
15–30% after 7 d N/A Collagen was found to function as a
bFGF reservoir in vivo
[178]
40–80% after 70 h N/A Collagen was found to function as a
bFGF reservoir in vivo and in vitro.
[178]
45% after 7 d Dual release of HGF and bFGF from
collagen enhanced blood vessel
formation.
N/A [108]
HGF 30% after 7 d N/A The affinity of HGF to collagen was
examined and compared with other
GFs.
[177]
35% after 7 d Dual release of HGF and bFGF from
collagen enhanced blood vessel
formation.
[108]
PDGF-BB 30% after 7 d N/A The affinity of PDGF-BB to collagen
was examined and compared with
other GFs.
[177]
VEGF <15% after 7 d N/A The affinity of VEGF to collagen was
examined and compared with other
GFs.
[177]
IGF-1 <5% after 7 d N/A The affinity of IGF-1 to collagen was
examined and compared with other
GFs.
[177]
HB-EGF <5% after 7 d N/A The affinity of H -EGF to collagen was
examined and compared with other
GFs.
[177]
rh-BMP2 N/A N/A Certain isotypes of rh-BMP2 have a







50–70% depending on cross-
linking concentration
compared with <10% for the
non- cross-linked system at
time point 0 h.
Increase in viability, invasion and
assembly of endothelial cells into the
collagen hydrogel compared with the
no VEGF and soluble VEGF groups.
N/A [193]
EGF PEGylated with
PEG-NHS and bound to
collagen
N/A Cell proliferation of cross-linked EGF
using PEG-NHS was lower compared
with the non- cross-linked condition
due to PEG sterically hindering cells of
attaching to the EGF properly.
Cell proliferation was highly
dependent on the site of EGF
PEGylation. PEGylation at the N-
terminus showed the best, albeit still
lower than non- cross-linked EGF,
and PEGylation at Lysine 48 the




96–98% after 120 h Cytokeratin (CK) 3/12 – an important
corneal epithelial cell differentiation
marker – was upregulated and tight
junction were observed between
adjacent cells.
No significant difference was
observed between the immobilized











60% in hydrogels with
heparan sulfate and 20%
without after 21 d
The collagen-HS-bFGF complex showed
extensive angiogenesis throughout the
hydrogels in vivo, which was not the






N/A Aided in keratinocyte migration in a
scratch assay as well as EGF-signaling
and HGF expression of fibroblast, which
affect keratinocyte differentiation. HA-
EGF containing hydrogels also resulted
in more effective wound healing
compared with the no-EGF group.
Sulfated hyaluronan increased EGF
binding to collagen compared with




60% in hydrogels with
heparan suldate and 20%
without after 250 h
N/A N/A [199]




N/A Gene expression analysis also revealed
that neural stem cells in the EGF-CBD-
Collagen expressed significantly more
stem cell, neuron, astrocyte and
oligodendrocyte associated markers
compared with unbound EGF. Cell





N/A FNCBD-VEGF121 showed a similar
bioactivity to soluble VEGF121 but
N/A [200]
(continued on next page)
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Mechanism of GF
loading




significantly increased the expression of
VEGFR-2, a receptor for VEGF – on
endothelial progenitor cells (EPCs). In
vivo experiments showed that the novel
chimeric growth factor could induce
EPC mobilization locally without
having a system effect on the cell type.
Other carrier Systems Collagen microgels
containing rhBMP-2.








rhVEGF was released in 8
days in collagenase and in 4
weeks in cell medium.
HUVEC cultures that show capillary
formation after 21 days, comparable
with a control with VEGF in solution.
N/A [203]
Magnetic GFs N/A The study showed that scaffolds
supported cell adhesion and
proliferation.
Magnetic nanoparticles did not leak





<1 ng/ml release with TrAP
over 49 h compared with 3
ng/ml without TrAP
TrAP-PDGF-BB functionalised
coverslips resulted in increased cell
proliferation compared with soluble
PDGF-BB in 2D. There was no
significant difference between collagen




S.O. Sarrigiannidis et al. Materials Today Bio 10 (2021) 100098e.g. BMP-2 to achieve the desired effect i.e. bone lesion closure but can
cause side-effects such as ectopic bone formation [182]. As GF concen-
tration increases, the hydrogel can become ‘crowded’, and steric hin-
drance could play an increasing role [63]. If there is increased
GF/molecule affinity to the collagen matrix, as Kanematsu et al. [177]
described for some GFs, the release cannot be described by simple
diffusion, but parameters such as the collagen–GF interaction strength
and the degradation rate of the collagen matrix bound to the GF need to
be taken into account. These are discussed in later sections of the article.
The diffusivity of proteins from a hydrogel follows the Sto-
kes–Einstein equation for diffusion of spherical particles in a fluid:
D ¼ ðkBTÞ=ð6πηRН Þ
D ¼ diffusivity, kB ¼ Boltzmann's constant, T ¼ temperature, η ¼ kine-
matic viscosity of fluid, RH ¼ hydrodynamic radius.
As the RH increases at constant T, the diffusivity of the protein out of
the hydrogel decreases. Apart from size/weight, RH also depends on pH,
which can greatly influence the number of water molecules attracted to
the protein diffusing through the hydrogel [63].
Equations based on Fick's law of diffusion can be used to calculate the
ratio of the amount of molecule released at time t to the total amount that












D ¼ diffusivity, L ¼ half-thickness of hydrogel.
This equation although straightforward is based on the assumption
that the diffusing molecule is spherical [183]. A simpler empirical




k ¼ constant that depends on structure and geometry, n ¼ release
exponent depending on geometry (e.g. cylinder n ¼ 0.45).
However, these empirical models can only predict a release profile
once experiments have been conducted and are not accurate once the
system has been changed in some capacity e.g. cross-linker increased. It is
also important to note that release models change according to the13geometrical parameters of the hydrogel [184,185].
As the mesh size of the hydrogel approaches the size of the molecule
to be released, steric hindrance increases, and the molecule of interest
does not diffuse easily out of the hydrogel, due to higher friction forces
[186]. Once the mesh size is smaller than the molecule size, the hin-
drance effect immobilizes it within the matrix, unless degradation or
mesh enlargement occurs due to swelling. Although hydrogels with a
very small mesh size can be engineered e.g. collagen-PEG systems [180],
many GF/molecule-loaded collagen systems have a mesh size far greater
than the hydrodynamic radius of the GF/molecule, and release is not
influenced by swelling or degradation.
Hydrogel swelling is influenced by various external stimuli including
temperature, light, glucose, salt concentrations, and pH [186–188].
Stimuli responding hydrogels are important when it comes to treating
diseases such as cancer, as their local environment, e.g. in terms of pH,
differs from healthy tissue. Collagen hydrogels that respond to pH and
various salts at different concentrations have been produced in the past.
Swelling increases from pH 2–4 due to the protonation of carboxyl groups
into carboxylic acid groups, decreasing the repulsive forces between
adjacent polymeric chains as charge is neutralized. Swelling starts
decreasing again as pH increases with a substantial drop observed from
pH 8–13. This is due to the formation of sodium carboxylate groups,
which shield collagen fibers from absorbing water. Similarly, adding
salts, especially at high concentrations has a similar shielding effect,
particularly if the salts are composed of divalent or trivalent cations
[188].
The diffusivity of a swollen hydrogel can be calculated using an













Ds ¼ diffusivity of swollen gel, Do ¼ diffusivity of molecule in pure sol-
vent, rs ¼ radius of molecule, Y ¼ ratio of the volume required for
molecule movement to be possible to the average free volume per
molecule of solvent (approximately 1 as the model is insensitive to the
parameter), v2,s ¼ ratio between polymer volume to the swollen gel





is possibly the most important and describes the
probability of a molecule of radius rs to diffuse through a swollen
Fig. 5. Collagen hydrogel systems
designed to deliver growth factor (GF) in
situ: The systems vary from simple where GF
is directly loaded into the hydrogel and
released by quickly diffusing into the extra-
cellular space, to chemically cross-linking the
GF to the hydrogel, which limits release but
can impede its bioactivity. More complex,
carrier delivery systems and hydrogel de-
signs can find a balance between the two
extremes and release GF in a sustained
manner without affecting its bioactivity.
CBD: collagen binding domain.
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Consequently, the ratio Mt/M∞ can be found as previously described.
An empirical way to calculate the ratio was also developed by Peppas and
Sahlin and considers both polymer relaxation and molecule diffusion
during swelling, which contribute to the release profile:
Mt
M∞
¼ k1tm þ k2t2m14k1, k2, and m ¼ geometry-dependent constants.
More complex models considering axial and radial diffusion as well as
polymer dissolution have been developed but are outwith the scope of
this article [185].
Another strategy used for GF release from a hydrogel is matrix
degradation. As the hydrogel matrix degrades through either hydrolysis
or enzymatic action (e.g. collagenase), the mesh size increases similar to
the swelling scenario. Most commonly, hydrogels are permeable to water
and enzymes allowing degradation to occur from both its surface and the
core. If the rate of matrix bonds breaking due to degradation is higher
than the rate of enzyme and water diffusion into the hydrogel, then
surface degradation occurs. When the opposite is true, bulk degradation
S.O. Sarrigiannidis et al. Materials Today Bio 10 (2021) 100098is predominant [189]. This phenomenon can be controlled by tuning the
hydrophilicity of the hydrogel and its sensitivity to enzymatic degrada-
tion. While synthetic hydrogels can be easily decorated with enzyme
cleavage sites and hydrophobic side chains to control these parameters,
in hydrogels made from natural polymers (e.g. collagen) this fine tuning
is not as straightforward and is either done through various degrees of
cross-linking [50] or the introduction of a secondary non-collagenous
phase [190]. The release profile from a degrading hydrogel can be
calculated similarly to swelling by calculating its diffusivity at a certain
timepoint. Empirical formulas for surface eroding hydrogels have also
been developed by Hopfenberg [191] and Katzhendler et al. [192]. It is
important to note that matrix degradation, in this case, results in an in-
crease of the mesh size. Matrix degradation can also foster GF/molecule
release when they are chemically bound to collagen, as will be discussed
later.
3.2. Chemical cross-linking of growth factors
To avoid rapid release of GF into the extracellular space, GFs can be
cross-linked to collagen. Chemical cross-linking with compounds such as
N-(3-dimethylaminopropyl)-N0-ethylcarbodiimidehydrochloride (EDAC)
is commonly used to cross-link collagen hydrogels but has also been used
to cross-link GFs to the hydrogel to improve their biological properties.
Shen et al. [193] used this technique to immobilize up to 70% of VEGF
(500 ng/ml) on collagen compared with <10% for the non-cross-linked
group. This promoted an increase in viability, invasion, and assembly of
endothelial cells into the collagen hydrogel compared with the no VEGF
and soluble VEGF groups. However, reactions that involve the cross--
linking of GFs to substrates through primary amines can lead to reduced
GF bioactivity as was observed for EGF in this study [194].
Another study involved riboflavin, a photosensitizer, and visible blue
light to immobilize EGF on the surface of collagen hydrogels in a dose-
dependent manner. Less than 2% of the cross-linked GF was released
from the collagen substrate in PBS after 120 h, suggesting that a strong,
covalent bond between collagen and EGF was established. Around 4%
was released after 120 h in the presence of 0.1 and 0.2% collagenase.
Collagen-EGF substrates outperformed plain collagen hydrogels in cell
proliferation studies, with and without the addition of soluble EGF.
Corneal epithelial cell differentiation was also observed when EGF
was immobilized on collagen substrates. Cytokeratin (CK) 3/12 – an
important corneal epithelial cell differentiation marker – was upregu-
lated and tight junctions were observed between adjacent cells. However,
no significant differences were observed between the immobilized EGF
and the soluble EGF group in terms of differentiation [195].
Although the primary purpose of chemically cross-linking GFs to the
hydrogel matrix is to immobilize them, hydrogel degradation can lead to
GF release into the extracellular space. To accurately predict the release
profile, mathematical models have been developed, which account not
only for mesh size change but also for the diffusion of matrix monomers
and consequently, bound GF from the hydrogel. Models by G€opferich and
Langer [196] have been developed for this purpose but are too extensive
for the purpose of this article.
3.3. Electrostatic and other protein–protein interaction
Chemical cross-linking can be an effectivemethod for GF presentation
but can lead to protein denaturation and inactivation. A strategy that
relies on the electrostatic or specific protein–protein interactions be-
tween GF and the ECM can alleviate this issue. There is substantial evi-
dence suggesting that GF binding to the ECM regulates their activity and
potency [206]. Bound GFs are also more resistant to proteolysis and
thermal denaturation [207] and are released more gradually into the
extracellular space [208]. IGFs, PDGF, VEGF, FGFs, and HGF among
others have increased affinity for some ECM proteins (e.g. fibronectin)
[206] as well as GAGs such as heparin and heparan sulfate (HS) which
are large, negatively charged sulfate polysaccharides [209,210]. ECM15proteins such as fibronectin have dedicated GF binding domains (e.g. FN
III12-14), which also bind GFs [206], while sulphation motifs are thought
to function as molecular recognition elements [210] of GAGs.
Researchers [197] showed that collagen hydrogels with HS showed a
threefold increase in bFGF binding capacity and a more sustained release
of the GF in vitro compared with collagen–hydrogels loaded with bFGF.
Collagen-HS-bFGF complex showed extensive angiogenesis throughout
the hydrogels over a 10-week incubation period in vivo, which was not
the case in the collagen-bFGF and collagen–HS hydrogels [197]. Another
study combined hyaluronan (HA) with collagen hydrogels, which
increased their binding strength to EGF over 72 h, and aided in kerati-
nocyte migration in a scratch assay together with EGF-signaling and HGF
expression of fibroblasts, thus affecting keratinocyte differentiation.
HA-EGF containing hydrogels also resulted in more effective wound
healing [198]. Collagen hydrogels have also been functionalized with
heparin giving rise to heparinized collagen matrices. These allowed for
better GF (namely bFGF) binding compared with conventional collagen
hydrogels [199].
Another approach for dedicated protein–protein interactions relies on
modifying GFs with specialized collagen binding domains (CBDs) to in-
crease their affinity to collagen. Egawa et al. [175] decorated GFs with
CBDs similar to the ones found on other ECM proteins such as laminin
and fibronectin. Plain collagen is inert for NSCs as it lacks sequences that
present trophic or anti-apoptotic signals. Epidermal growth factor (EGF),
a knownmitogen for NSCs, was fused to a CBD and incorporated into cell
containing collagen hydrogels. Indeed, significantly more NSCs were
alive in the EGF–CBD–collagen hydrogel compared with the EGF–colla-
gen hydrogel. Gene expression analysis also revealed that cells in the
EGF–CBD–collagen expressed significantly more stem cell-, neuron-,
astrocyte-, and oligodendrocyte-associated markers. Thus, coupling GFs
with a CBD allowed for a more sustained release and effective presen-
tation of the GF to cells while the plain EGF diffused out of the hydrogel
too quickly to have a biological effect [175]. Although this technique
alleviates the quick release problem, it requires the production of
modified GFs, which can be expensive and is highly specific. In another
study [200], fibronectin collagen binding domain (FNCBD) was fused to
GF, namely VEGF121, to allow more effective binding to collagen type I,
II, II, IV, and V substrates. FNCBD-VEGF121 showed a similar bioactivity
to soluble VEGF121 but significantly increased the expression of
VEGFR-2, a receptor for VEGF on endothelial progenitor cells (EPCs)
confirming the importance of appropriate GF presentation to elucidate an
appropriate cell response. In vivo experiments showed that the novel
chimeric GF could induce EPC mobilization locally without having a
systemic effect on the cell type.
Instead of modifying GFs, collagens with GF binding sequences from
other ECM proteins can be produced recombinantly. Parmar et al. [211]
developed a collagen-mimetic hydrogel system to enhance chondro-
genesis. A protein containing the characteristic repeating (Gly-X-Y)
backbone that can be found in collagens was expressed in Streptococcus
pyogenes. Heparin-binding sequences were added to the collagen
construct. These hydrogels displayed increased heparin absorption
compared with collagen-like hydrogels without the heparin-binding
sequence. The former also exhibited higher chondrogenic marker gene
expression (i.e. COL2A1, ACAN, and SOX9) in MSCs cultured on the gels.
This is because the heparin-binding sites present within the hydrogel
bind to endogenous GFs such as TGF-β, BMPs, and bFGF, protecting them
from degradation and prolonging their stability and thus biological
benefit.
GF release from hydrogels that have affinity for them can also be
modeled. The diffusivity can be calculated assuming that it is possible to




D ¼ diffusivity, Kb ¼ concentration of bound protein/concentration of
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concentration of free protein, t ¼ time.
This model, although useful, assumes a rapid binding mechanism and
the availability of many free GF binding sites. In addition, swelling and
degradation need to be considered separately.
3.4. Microcarrier systems
If the GF presentation and release timeline is still inadequate, the
exposure of GF from a hydrogel to the extracellular environment can be
further controlled by incorporating carrier systems such as GF-containing
microgels into the system.
3.4.1. Microgels
Microspheres or microgels have emerged in recent years as an
effective type of drug delivery system, showing advantages such as
tunable size, increased surface area, large attachment surface for cells,
and injectability. They range from a size of a few nanometers to hundreds
of microns [212,213]. A reduced size of particles makes possible their use
in minimally invasive procedures. There are several methods for the
production of microgels based on collagen or other biopolymers, which
are reviewed in more detail in Refs. [214,215] and include emulsification
[123,216], extrusion, atomization, deposition [217,218], membrane
emulsification [219], microfluidics [220–224], or bioprinting [225].
Several groups have investigated collagen microgels for drug encap-
sulation in different tissue engineering applications. Mumcuoglu, Fahmy-
Garcia et al. have described in detail a system consisting of recombinant
collagen peptide microspheres encapsulating rhBMP-2 for bone regen-
eration [123,201,202]. The microgels, produced by emulsification and
chemically cross-linked with HDMI, had a slight burst release that
decreased with chemical cross-linking. All collagen compositions showed
a very strong retention of the GF, with 80% of the rhBMP-2 contained
after 2 weeks. Surface plasma resonance data suggest a specific interac-
tion between the N-terminal of BMP-2 and collagen [123]. The same
microsphere system encapsulating adipose-derived stromal cells was
used by other groups for myocardial infarction and cardiac regeneration
[216,226] and tested it with in vivo models. The authors also reported a
more marked reduction of the burst release in 50 and 70 μm spheres
compared with the 200 μm spheres. This behavior is not generally ex-
pected, as greater particles provide a greater diffusion pathway for
encapsulated molecules, and should thus show more delayed release
[227]. Nevertheless, other researchers have encountered a similar
behavior in other microparticle systems and linked it to increased loading
in particles of greater diameter. Increased initial loading capacity of
bigger particles means that, once depleted of a fraction of encapsulated
molecules, the particles will have an increase in porosity from the
missing encapsulated molecules that compensates for their longer
diffusion pathways, this way enhancing the diffusivity through their
matrix [228].
Also aiming at bone regeneration, Sears et al. have reported acryl-
ate–PEG–collagen microgels produced in a flow-focusing microfluidic
device [229] and encapsulating an inhibitor of peroxisome
proliferator-activating receptor gamma, GW9662 (GW). The same au-
thors had previously reported pro-osteogenic MSC phenotype as a result
of such inhibition by upregulation of cWnt pathway [230]. Nagai et al.
encapsulated rhVEGF in collagen microspheres of 3–50 μm diameter,
synthetized by water-in-oil emulsification and cross-linked with
EDC/NHS [203]. rhVEGF was released in 8 days in 1 U/ml collagenase
and in 4 weeks in EGM (HUVEC-specific growth medium), whereas a
significantly reduced amount escaped the gels in PBS media. This was
attributed to a degradation-driven mechanism of release, although the
authors also point toward an effect of a solvent-dependent change. The
authors claim GF released is bioactive on HUVEC cultures as they showed
capillary formation after 21 days, comparable with a control with VEGF
in solution. The same group used collagen microspheres as rhBDNF res-
ervoirs attached to a PEG dimethacrylate membrane in a transscleral16drug-delivery device for ophthalmic applications [231]. Collagen
microgels have also been generated for applications other than GF de-
livery, like stem cell delivery [216], 3D cell culture platforms [232] or
microtissue generation [220].
3.4.2. Other carrier systems
A magnetic collagen scaffold was developed by Bock et al. by
immersing it into an aqueous solution of ferrofluids containing iron oxide
nanoparticles. These materials were designed to function as refillable, in
vivo GF reservoirs by attracting magnetically functionalized GFs. The
study showed that scaffolds supported cell adhesion and proliferation
and that magnetic nanoparticles did not leak out of the scaffold over
time. However, its ability to recruit GFs is still unexplored [204].
Stejskalova et al. [205] proposed a very innovative GF delivery
platform, which is inspired by the large latent complex (LLC) that re-
strains TGF-β. During wound healing, TGF-β is deposited in an inactive
state throughout the ECM, restricted by a protein complex called the LLC.
As the wound heals, cells attach to the LLC via an RGD sequence releasing
TGF-β, which aids in the healing process. In this study, collagen hydro-
gels among other scaffolds were decorated with a similar system, named
Traction Force Activated Payloads (TrAP), which binds VEGF and
PDGF-BB in an inactive state until it is released by a binding cell exerting
force on the system. The system can be designed to selectively respond to
different cell types depending on the cell binding sequence attached to
the TrAP e.g. while human smooth muscle cells attach to the VAPG amino
acid sequence, human dermal fibroblasts do not. However, while
TrAP-PDGF-BB functionalized coverslips resulted in increased cell pro-
liferation compared with soluble PDGF-BB in 2D, there was no significant
difference between collagen hydrogels loaded with PDGF-BB and
TrAP-PDGF-BB decorated collagen hydrogels in 3D. Cell differentiation,
another potential application of interest, has not been explored yet.
4. Conclusion and future work
Hydrogel design in tissue engineering has gained a high degree of
sophistication in recent years by using novel strategies for their func-
tionalization. Collagen is one of the first biomaterials described in the
tissue engineering field, and it is still chosen for its numerous advantages,
together with its well-studied properties that have also gained the con-
fidence of several regulatory bodies as an implant system.
Modification of collagen to improve its mechanical properties in
terms of strength, elasticity or compliance can further expand their
translation in load-bearing applications. For instance, in the production
of vascular conducts already available in the clinic, Ominiflow II
(LeMaitre Vascular) uses glutaraldehyde-tanned ovine collagen cross-
linked with a polyester mesh that provides strength and durability to
resist aneurism formation [233]. Also in the vascular engineering field, a
collagen-based bioprosthesis obtained by a process of glutaraldehyde
cross-linking and gamma irradiation is currently used in the clinic [234].
In terms of bone regeneration, Boston Scientific's Infuse uses an Achil-
les-tendon-derived soft collagen sponge, with hemostatic properties and
whose degradability is controlled by a proprietary technology [235,236].
In the form of hydrogels, collagen is used as wound dressings to augment
tissue growth and accelerate wound closure, in an application
where mechanical integrity of the medical device is paramount [237].
Vergenix is another example of physically cross-linked collagen of re-
combinant source used together with platelet-rich plasma as an injectable
matrix for tendinopathy and in wound healing applications [238,239].
Tissue-specific GFs are important participants in the tissue regener-
ation process as they dictate cell fate by participating in vital biological
pathways [240]. Cells interact with the GFs in two ways: uptaking the
soluble GFs from the surrounding media or interacting via receptors with
GFs bound to dedicated sites (heparin domains) of some ECM proteins
such as fibronectin and laminin [240]. Collagen, a widely used substrate
for tissue engineering, does not exhibit these dedicated binding sites but
has still been commercialized for use in conjunction with GFs [175], e.g.
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PDGF [242]. These products have been successful in regenerating bone
and treating ulcers, respectively, but the amount of GF loaded (1.5
mg/ml BMP2 [241] and 100 μg/g PDGF [242], respectively) far sur-
passes physiological levels of the GFs, resulting in side-effects such as
ectopic bone formation andmalignant growths [243,244]. Consequently,
there is a real clinical need to develop new methods, in collagen-based
materials, to present GFs locally at low concentrations, which have the
same biological effect as the current state-of-the art. Particularly prom-
ising approaches rely on custom GFs covalently cross-linked with CBD
sequences [175,200]. Incorporating different molecules such as GAGs
into the collagen matrix is another simple but effective approach because
GAGs such as hyaluronan and chondroitin have higher affinity to some
GFs compared with collagen [197,198]. More advanced carrier systems,
such as TrAP, have also been engineered to deliver GFs in-situ using
peptides triggered by forces exerted by cells to their local microenvi-
ronment [205].
The ability to control the mechanical properties and degradation of
collagen hydrogels and sustain GF release is a great tool to optimize
systems for use in different tissue environments. This is confirmed by in
vitro and in vivo studies, which demonstrate that newly developed
collagen systems have the potential to be used in clinical studies in the
future. Still, studies using collagen systems, with exceptions (e.g.
Ref. [78]), often approach the topic from a one-sided perspective and do
not consider both mechanical and biological stimuli (e.g. GF loading)
simultaneously.
Collagen hydrogels in tissue engineering have seen massive im-
provements in recent years that have laid important groundwork for
future developments. However, these hydrogels still lack essential
properties of the native ECM. For instance, similarly to other systems in
the field, encapsulated co-cultures within the gel or the utilization of
combinations of GFs at optimized concentrations for tissue growth are
still in its infancy. Furthermore, GF release from collagen gels typically
include an initial burst release. It is urgent to engineer collagen hydrogels
that offer full control on the release kinetics of GFs, to recapitulate sus-
tained local concentrations found in vivo. Finally, the scalability, shelf
life, and handling of collagen hydrogels needs to be analyzed and
improved for them to become the material of choice for surgeons in the
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